QQ客服 官方微博 反馈留言

	Aberrant Methylation of PCDH10 Predicts Worse Biochemical Recurrence-Free Survival in Patients with Prostate Cancer After Radical Prostatectomy
	Wang, Li[1]; Xie, Pei-Gen[2]; Lin, Ying-Li[3]; Ma, Jian-Guo[4]; Li, Wen-Ping[5]
刊名	MEDICAL SCIENCE MONITOR
	2014
卷号	20
关键词	Biological Markers DNA Methylation Prostatic Neoplasms
ISSN号	1643-3750
URL标识	查看原文
收录类别	SCI(E)
WOS记录号	WOS:000340044200001
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5403413
专题	江苏大学
作者单位	1.[1]Hebei Univ Engn, Affiliated Hosp, Dept Urol, Handan, Peoples R China. 2.[2]Sun Yat Sen Univ, Affiliated Hosp 3, Dept Spine Surg, Guangzhou 510275, Guangdong, Peoples R China. 3.[3]Jiangsu Univ, Affiliated Xuzhou Hosp, Xuzhou Tumor Hosp, Dept Urol, Xuzhou, Peoples R China. 4.[4]Hebei Med Univ, Hosp 3, Dept Urol, Shijiazhuang, Peoples R China. 5.[5]Hebei Med Univ, Hosp 3, Dept Urol, Shijiazhuang, Peoples R China.
推荐引用方式 GB/T 7714	Wang, Li[1],Xie, Pei-Gen[2],Lin, Ying-Li[3],et al. Aberrant Methylation of PCDH10 Predicts Worse Biochemical Recurrence-Free Survival in Patients with Prostate Cancer After Radical Prostatectomy[J]. MEDICAL SCIENCE MONITOR,2014,20.
APA	Wang, Li[1],Xie, Pei-Gen[2],Lin, Ying-Li[3],Ma, Jian-Guo[4],&Li, Wen-Ping[5].(2014).Aberrant Methylation of PCDH10 Predicts Worse Biochemical Recurrence-Free Survival in Patients with Prostate Cancer After Radical Prostatectomy.MEDICAL SCIENCE MONITOR,20.
MLA	Wang, Li[1],et al."Aberrant Methylation of PCDH10 Predicts Worse Biochemical Recurrence-Free Survival in Patients with Prostate Cancer After Radical Prostatectomy".MEDICAL SCIENCE MONITOR 20(2014).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。